Pablo J. Cagnoni, President and Global Head of R&D at Incyte Corp, filed a Form 4 on August 20, 2026, disclosing the sale of 10,801 shares of common stock on August 19, 2026, pursuant to a Rule 10b5-1 trading plan.

Key Highlights

  • Shares sold: Pablo J. Cagnoni disposed of 10,801 shares of Incyte Corp common stock on August 19, 2026.
  • Sale price: The shares were sold at $125.56 per share.
  • 10b5-1 plan: The filing indicates the transaction was made pursuant to a contract, instruction, or written plan satisfying the affirmative defense conditions of Rule 10b5-1(c).
  • Remaining ownership: Following the transaction, Cagnoni directly beneficially owned 183,200 shares.
  • Unvested equity included: The 183,200-share total includes shares issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
  • Role: Cagnoni is identified in the filing as an officer with the title President, Global Head of R&D.

Incyte Corp R&D Chief Disposes of Common Stock in Planned Sale

According to the Form 4 filed with the SEC on August 20, 2026, Pablo J. Cagnoni, President and Global Head of R&D at Incyte Corp (NASDAQ:INCY), disposed of 10,801 shares of the company's common stock on August 19, 2026, at a price of $125.56 per share. The filing indicates the transaction bears transaction code "S," designating an open-market or plan-based sale.

The filing notes that the sale was executed pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), as indicated by the checkbox on the form. Following the reported transaction, Cagnoni's direct beneficial ownership stood at 183,200 shares. The filing clarifies in a footnote that this total "includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested."

No derivative securities transactions were reported in Table II of the filing. The Form 4 was signed by Elizabeth Feeney as Attorney-In-Fact on behalf of the reporting person, and was filed on August 20, 2026, reflecting a transaction date of August 19, 2026.

What Was Disclosed

Pablo J. Cagnoni, an officer of Incyte Corp, disclosed the sale of 10,801 shares of common stock at $125.56 per share under a Rule 10b5-1 plan, with 183,200 shares of beneficial ownership reported following the transaction, including unvested restricted and performance stock units.